Table 1.

Baseline characteristics of 12 severely immunosuppressed AIDS patients enrolled in AAIT

Patient	Gender	Age (years)	Transmission route	Laboratory examinations										Viral nucleic acid				ART relative to initiation of AAIT (days)	Times of transfusion	Dose of each transfusion 108/kg
				HIV RNA (copies/ml)	CD4 (cells/μl)	CD8 (cells/μl)	WBC (109/L)	RBC (1012/L)	PLT (109/L)	HGB (g/L)	ALT (U/L)	AST (U/L)	Cre (μmol/L)	CMV (IU/ml)	EBV (IU/ml)	HBV (copies/ml)	HCV (copies/ml)
01-W	M	36	Heterosexual	<20	33	602	5.43	3.37	352	105	9	18	81	<100	2.58E+02	<40	<50	−104	5	3/2.5/2.5/ 2.5/2.5
02-Z	M	28	Heterosexual	2.17E+04	7	227	1.31	2.59	136	78	20	42	53	<100	1.97E+02	<40	<50	−28	4	3/3.1/3/3
03-G	M	18	Homosexual	2.32E+06	9	688	3.15	4.18	131	121	58	35	74	<100	<100	<40	<50	−5	3	3/3.5/2.6
04-D	M	35	Homosexual	1.62E+02	1	40	1.75	3.05	170	87	18	24	63	4.17E+02	<100	<40	<50	−58	3	2.6/2.9/2.9
05-Z	M	29	Homosexual	8.88E+05	32	778	1.88	4.41	142	127	95	68	88	<100	<100	<40	<50	+20	3	3/2.6/2.6
06-L	M	44	Homosexual	1.01E+06	11	90	6.25	4.38	394	128	40	38	62	1.74E+04	6.64E+02	<40	<50	−10	2	3/2.5
07-X	M	34	Unknown	1.76E+07	4	590	3.16	4.44	239	127	29	46	84	<100	<100	<40	<50	−6	3	3.5/3/3
08-D	M	54	Homosexual	2.20E+05	10	268	7.09	4.66	325	151	33	18	85	<100	<100	<40	<50	+8	2	3/3
09-L	F	31	Heterosexual	1.25E+07	13	474	4.27	3.96	87	127	94	98	47	1.27E+03	<100	<40	<50	+2	3	3.3/3.2/3.2
10-L	M	35	Heterosexual	4.47E+05	20	374	4.32	3.76	278	121	47	27	74	<100	<100	<40	<50	+7	2	3.5/2.6
11-S	M	39	Unknown	2.53E+05	7	258	2.29	5.83	281	165	59	39	69	<100	<100	<40	<50	−3	2	3.1/3
12-L	M	27	Homosexual	8.86E+04	15	459	2.87	4.63	106	133	112	32	72	3.04E+04	<100	<40	<50	+2	2	3.3/3

“−” means ART before AAIT treatment, “+” means ART after AAIT treatment

M male, F female, WBC white blood cell, RBC red blood cell, PLT platelet, HGB hemoglobin, ALT alanine aminotransferase, AST glutamic oxaloacetic transaminase, Cre creatinine, CMV cytomegalovirus, EBV Epstein–Barr virus, HBV hepatitis B virus, HCV hepatitis C virus